Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan ^|ᵐdash;2012 Version

Key Points

• Provide standardized clinical recommendations for the diagnosis, management, and prevention of atherosclerotic cardiovascular diseases linked to dyslipidemia.
• Synthesized clinical evidence and expert consensus to formulate targeted prevention and diagnostic guidelines.
• Focused on primary manifestations of atherosclerotic disease, including coronary artery disease, cerebrovascular disease, and peripheral arterial disease.
• Established comprehensive clinical frameworks connecting dyslipidemia control directly with reduced risk of major vascular complications.
• Defined unified diagnostic and preventative criteria across coronary, cerebral, and peripheral arterial vascular beds.